Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients
Completed · Not applicable
Conditions studied: Lung Transplant Infection, Fungal Infection
In brief
This is a single center, observational study of posaconazole PK sampling in lung transplant recipients. The patients enrolled will have up to 6 (3ml) pk samples (a total of 18 ml) and one 10ml blood sample for a total collection of 28ml of blood obtained over the entire study. In addition, the investigators will collect medical record information and any excess BAL samples available during the study (tests done as part of the patient's clinical care and the samples would have been discarded once diagnosis was made).
Key facts
- Study ID
- NCT01419678
- Run by
- University of Pittsburgh
- People needed
- 20
- Starts
- 2011-10-01
- Expected to finish
- 2014-12-01
- Last updated by the study team
- 2014-12-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age and older receiving posaconazole post transplant as part of their care received a lung transplant
You may not qualify if…
- must meet inclusion criteria
Where it is running
- UPMC — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.